An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920
Clinical trial NCT04759339 · COMPLETED
Trial details
- NCT number
- NCT04759339
- Sponsor
- American Genomics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2021-02-25
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.